4,075 Shares in STERIS plc (NYSE:STE) Purchased by Gilliland Jeter Wealth Management LLC

Gilliland Jeter Wealth Management LLC acquired a new position in STERIS plc (NYSE:STE) during the 4th quarter, HoldingsChannel reports. The fund acquired 4,075 shares of the medical equipment provider’s stock, valued at approximately $896,000.

Several other institutional investors also recently bought and sold shares of STE. Impax Asset Management Group plc boosted its holdings in STERIS by 419.1% in the 4th quarter. Impax Asset Management Group plc now owns 964,935 shares of the medical equipment provider’s stock worth $211,430,000 after buying an additional 779,038 shares during the last quarter. Envestnet Asset Management Inc. boosted its holdings in STERIS by 58.4% in the 3rd quarter. Envestnet Asset Management Inc. now owns 586,380 shares of the medical equipment provider’s stock worth $128,663,000 after buying an additional 216,113 shares during the last quarter. Artemis Investment Management LLP purchased a new position in STERIS in the 4th quarter worth approximately $32,687,000. Jennison Associates LLC lifted its stake in STERIS by 60.2% in the 4th quarter. Jennison Associates LLC now owns 268,029 shares of the medical equipment provider’s stock worth $58,926,000 after purchasing an additional 100,734 shares in the last quarter. Finally, Lord Abbett & CO. LLC lifted its stake in STERIS by 65.5% in the 3rd quarter. Lord Abbett & CO. LLC now owns 244,659 shares of the medical equipment provider’s stock worth $53,683,000 after purchasing an additional 96,800 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have weighed in on STE shares. TheStreet raised shares of STERIS from a “c+” rating to a “b” rating in a research note on Wednesday, February 7th. KeyCorp started coverage on shares of STERIS in a research note on Tuesday, February 6th. They issued an “overweight” rating and a $253.00 target price on the stock. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research note on Friday, April 12th. JMP Securities reissued a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research note on Thursday, February 8th. Finally, Stephens reissued an “overweight” rating and issued a $250.00 target price on shares of STERIS in a research note on Friday, February 9th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, STERIS currently has an average rating of “Moderate Buy” and an average target price of $239.60.

STERIS Trading Up 1.2 %

Shares of STE stock traded up $2.36 during trading on Friday, hitting $203.90. 318,142 shares of the stock traded hands, compared to its average volume of 558,812. The firm has a market capitalization of $20.15 billion, a P/E ratio of 35.71 and a beta of 0.79. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.43 and a quick ratio of 1.49. The firm’s fifty day moving average price is $221.18 and its 200-day moving average price is $216.73. STERIS plc has a 52-week low of $181.78 and a 52-week high of $254.00.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 7th. The medical equipment provider reported $2.22 EPS for the quarter, beating the consensus estimate of $2.17 by $0.05. The firm had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.35 billion. STERIS had a net margin of 10.48% and a return on equity of 13.67%. The business’s revenue for the quarter was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.02 EPS. As a group, research analysts forecast that STERIS plc will post 8.67 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 22nd. Shareholders of record on Friday, February 23rd were given a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 1.02%. The ex-dividend date was Thursday, February 22nd. STERIS’s payout ratio is 36.43%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.